EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression

Justus Dann, Katharina Klöster, Ulas Ceylan, Neele Heitmann, Britta Eggers, Svitlana Rozanova, Martin Eisenacher, Katrin Marcus-Alic, Konstanze F Winklhofer, Ralf Gold, Simon Faissner

Cellular and Molecular Neurobiology · 2026

DOI: 10.1007/s10571-026-01775-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Neurobiology, 2026. Verfasst von Justus Dann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany. Hauptthemen laut MEDLINE: Microglia, Mitochondria, Fumarates, Iron. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ruhr-Universität Bochum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fumaric acid esters have proven to be effective medications in relapsing-remitting multiple sclerosis with neuroprotective effects. In this study, we investigated the impact of fumaric acid esters on primary murine microglia in vitro compared to DMSO vehicle control. Monomethyl fumarate (MMF) increased MTT reduction in a dose-dependent manner, whereas dimethyl fumarate (DMF) exhibited a biphasic response with low concentrations enhancing MTT reduction and higher concentrations inducing toxicity. Notably, complementary analyses of cell number and cell death did not reveal differences between MMF-treated and control conditions, indicating that the increased MTT reduction reflects enhanced cellular metabolic activity rather than increased viability. Consistent with this interpretation, MMF-treated cells exhibited higher basal and maximal oxygen consumption, spare respiratory capacity, and ATP production in the Seahorse XF Cell Mito Stress Test. Proteomic analysis did not indicate an upregulation of mitochondrial respiratory chain proteins, but instead suggested a qualitative shift in mitochondrial homeostasis, including increased expression of mitophagy-associated proteins. MMF-treated Nrf2-deficient microglia showed a blunted increase in MTT reduction, suggesting an involvement of Nrf2 in mediating MMF-induced metabolic effects. Additionally, MMF modulated the microglial iron metabolism and reduced the uptake of non-transferrin-bound iron and altered the gene expression of iron transport proteins, promoting a shift toward the uptake of less toxic, transferrin-bound iron. MMF mitigated iron-induced toxicity and was associated with upregulation of the ferroptosis suppressor protein, indicating a protective response to iron overload. Together, these findings suggest that MMF enhances microglial metabolic activity and mitochondrial function while reducing iron-mediated toxicity, thereby contributing to its neuroprotective effects. Graphical Abstract Summary of the proposed cellular effects of monomethyl fumarate in primary murine microglia. Created in BioRender. Faissner (2026). https://help.biorender.com/hc/en-gb/articles/17605511350685

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaMitochondriaFumaratesIronMultiple SclerosisMaleatesDisease ProgressionAnimalsMiceMice, Inbred C57BLCells, CulturedDimethyl FumarateNF-E2-Related Factor 2

Stichwörter der Autor:innen

MicrogliaMitochondriaNeuroinflammationNeuroprotectionProgressive multiple sclerosis

Substanzen

FumaratesIroncitraconic acidMaleatesDimethyl FumarateNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany.
  • Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, Bochum, Germany.
  • Medical Proteome Analysis, Center for Protein Diagnostics (PRODI), Ruhr-University Bochum, Bochum, Germany.
  • Core Unit for Bioinformatics (CUBiMed.RUB), Medical Faculty, Ruhr-University Bochum, Bochum, Germany.
  • Department Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr- University Bochum, Bochum, Germany.
  • Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany. simon.faissner@rub.de.

Förderung

  • Ruhr-Universität Bochum

Zitieren

APA

Dann, J., Klöster, K., Ceylan, U., Heitmann, N., Eggers, B., Rozanova, S., Eisenacher, M., Marcus-Alic, K., Winklhofer, K. F., Gold, R., & Faissner, S. (2026). Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01775-x

Vancouver

Dann J, Klöster K, Ceylan U, Heitmann N, Eggers B, Rozanova S, et al. Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression. Cellular and Molecular Neurobiology. 2026. doi:10.1007/s10571-026-01775-x

BibTeX
@article{Dann2026,
  author = {Dann, Justus and Klöster, Katharina and Ceylan, Ulas and Heitmann, Neele and Eggers, Britta and Rozanova, Svitlana and Eisenacher, Martin and Marcus-Alic, Katrin and Winklhofer, Konstanze F and Gold, Ralf and Faissner, Simon},
  title = {Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression},
  journal = {Cellular and Molecular Neurobiology},
  year = {2026},
  doi = {10.1007/s10571-026-01775-x}
}
Kostenlos starten →